Source: ERJ Open Res, 7 (2) 00437-2020; 10.1183/23120541.00437-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mathieu Fieldes, Chloé Bourguignon, Said Assou, Amel Nasri, Aurélie Fort, Isabelle Vachier, John De Vos, Engi Ahmed, Arnaud Bourdin. Targeted therapy in eosinophilic chronic obstructive pulmonary disease. ERJ Open Res, 7 (2) 00437-2020; 10.1183/23120541.00437-2020

Member's Comments

No comment yet.

Related content which might interest you: Bronchodilators in chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=266 Year: 2006 Therapeutic responses in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Immunological profiling of chronic obstructive airways disease and idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Bifunctional drugs for the treatment of asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2014; 44: 475-482 Year: 2014 Minimal bronchiectasis in chronic obstructive pulmonary disease Source: Annual Congress 2009 - Quality of life and symptoms in COPD Year: 2009 Periodontitis and chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Disease of the airways in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 41S-49S Year: 2001 Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 21: 58-67 Year: 2003 Principles of diuretic therapy of oedema syndrome in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 626s Year: 2006 Chronic obstructive pulmonary disease Source: Eur Respir Monogr 2015; 70: 80-98 Year: 2015 Chronic obstructive pulmonary disease Source: Eur Respir Monogr 2014; 65: 1-17 Year: 2014 Chronic obstructive pulmonary disease Source: Eur Respir Mon; 2009: 45: 25–31 Year: 2009 Chronic obstructive pulmonary disease Source: Eur Respir Monogr 2013; 62: 1-18 Year: 2013 Inferon efficacy in the treatment of chronic obstructive pulmonary disease Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Systemic and pulmonary inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008